RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
Glen Rock, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx”…
Year: 2021
Myriad Genetics Provides Transformation Update, Pursues Strategic Alternatives for Autoimmune Business, Realigns International Operations
Focus on Women’s Health, Oncology, Mental Health to Improve Execution and Accelerate Growth SALT LAKE CITY,…
Organogenesis Holdings Inc. to Participate in the ICR Conference 2021
CANTON, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Kymera Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021
WATERTOWN, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical…
Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS),…
Nabriva Therapeutics to Participate in Upcoming Virtual Investor Conferences in January
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics…
Histogen Announces Closing of $14.0 Million Upsized Public Offering
SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (Nasdaq: HSTO), a clinical-stage therapeutics…
CORRECTION — Myovant Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
BASEL, Switzerland, Jan. 05, 2021 (GLOBE NEWSWIRE) — In a release issued under the same…
Inventiva announces design of Phase III clinical trial with lanifibranor in NASH
A single global Phase III clinical trial evaluating two doses of lanifibranor (800mg and 1200mg…
Aerpio Announces Strategic Review after Topline Results from Razuprotafib Glaucoma Phase 2 Trial
CINCINNATI, Jan. 05, 2021 (GLOBE NEWSWIRE) — Aerpio Pharmaceuticals, Inc. (“Aerpio” or the “Company”) (Nasdaq:…
OSE Immunotherapeutics Presentation at H.C. Wainwright BIOCONNECT 2021 Virtual Conference
NANTES, France, Jan. 05, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today…
CORRECTING and REPLACING – GW Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
LONDON and CARLSBAD, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — In a release issued earlier…
Exterro Granted Patent for Ground-Breaking Gateway Coordinator Technology
The company’s game-changing technology innovation optimizes data collection, processing, and transfer of on-premises data to…
Goodbody Boosts Marketing Agility with Progress
With Progress Sitefinity Cloud, Ireland’s leading brokerage quadrupled its account openings through customer-centric digital transformation…
John Snow Labs Announces State-of-the-Art Enhancements to its Spark NLP Technology, Resulting in 2.5M Downloads and 9x Growth in 2020
Spark NLP ranked by data scientists as the most popular and accurate NLP solution on…
Sidetrade ranked a “Major Player” in the order-to-cash market by IDC
Sidetrade (Euronext Growth: ALBFR.PA), the artificial intelligence platform dedicated to accelerating company revenue and cashflow,…
Constellation Software Inc. Completes Spin-Out of Topicus.com Inc.
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) — Constellation Software Inc. (“Constellation”) (TSX:CSU) and Topicus.com Inc….
Mediwelcome: Reasonable valuation with HK listing on track for January 19
HONG KONG, Jan 6, 2021 – (ACN Newswire) – With the improvement in China’s economic…
Deeper Network Wins Web3 Foundation Grant to Build Critical Web 3.0 Infrastructure for the Polkadot Ecosystem
PALO ALTO, CA, Jan 6, 2021 – (ACN Newswire) – Deeper Network, an official member…
Onfido and FundOf to Empower Content Creators to Monetize Their Work Through Trusted Transactions on Any Platform
Hong Kong-based fintech and social media startup FundOf teams up with AI-based identity company Onfido…